People – Page 2
-
NewsBiologist examines growth patterns in bacteria to help develop more targeted, effective antibiotics
Among the new investigative projects at the University of Texas at Arlington is one headed by Dr. Cara Boutte, who is studying how certain bacteria grow by examining how they build their cell walls, an effort that could lead to the development of more effective antibiotics.
-
NewsAMI makes The Sunday Times Best Places to Work in the UK list - twice!
Applied Microbiology International is celebrating after making The Sunday Times Best Places to Work in the UK list for the second year in a row.
-
NewsPhage expert Graham Hatfull elected as a Fellow of the Royal Society
Graham Hatfull, Eberly Family Professor of Biotechnology and HHMI Professor in the University of Pittsburgh Kenneth P. Dietrich School of Arts and Sciences, has been named a Fellow of the Royal Society.
-
NewsGlobal leaders reaffirm commitment to WHO with at least US$ 170 million raised at World Health Assembly 2025 pledging event
World leaders pledged at least an additional US$ 170 million to the World Health Organization (WHO) at a high-level pledging event Tuesday at the Seventy-eighth World Health Assembly in Geneva.
-
NewsWorld Health Assembly adopts historic Pandemic Agreement to make the world more equitable and safer from future pandemics
Member States of the World Health Organization (WHO) today formally adopted by consensus the world’s first Pandemic Agreement, following more than three years of intensive negotiations launched by governments in response to the COVID-19 pandemic.
-
NewsWHO validates Mauritania for eliminating trachoma as a public health problem
The World Health Organization (WHO) has validated Mauritania as having eliminated trachoma as a public health problem, making it the seventh country in WHO’s African Region to achieve this significant milestone.
-
NewsA turning point in medicine: phage therapy moves from promise to practice
From June 10–11, 2025, the international scientific and medical community will gather in Berlin for Targeting Phage Therapy 2025, the leading global event focused on translating phage research into clinical reality.
-
NewsPapua New Guinea eliminates trachoma as a public health problem
Papua New Guinea (PNG) has been validated by the World Health Organization (WHO) for eliminating trachoma as a public health problem. Trachoma, the world’s leading infectious cause of blindness, no longer poses a public health threat in the country.
-
NewsThe Global Fund to fight AIDS, Tuberculosis and Malaria ‘should step up efforts’
The international community must protect global responses to HIV, tuberculosis (TB), and malaria to serve humanity’s collective interests, according to a new opinion article.
-
NewsResearchers and students transform Milan into outdoor lab for ambitious citizen science urban microbiome study
Researchers and students from the University of Milano-Bicocca - including AMI student member Giulia Ghisleni - teamed up for an ambitious citizen science project, collecting more than 2,400 samples of the urban microbiome over four seasons.
-
NewsScientist awarded $500,000 Gruber Genetics Prize for pioneering discoveries in bacterial immune systems
The 2025 Gruber Genetics Prize is being awarded to geneticist and molecular biologist Rotem Sorek, Ph.D., of the Weizmann Institute of Science, for his discoveries in the immune system of bacteria.
-
NewsFirst all-oral treatment for a rare but deadly strain of sleeping sickness now available
A handful of patients in Ethiopia, Malawi, Tanzania, Zambia, and Zimbabwe, as well as foreign travellers, have now been treated with a medicine that is revolutionizing care for patients with rhodesiense sleeping sickness.
-
NewsVote now! AMI names the 15 candidates vying for Trustee election
Applied Microbiology International (AMI) is calling on all members to vote in the Trustee election. Voting opens for the AMI Trustee election on May 14.
-
NewsNew film series ‘The Deadly Five’ highlights global animal infectious diseases
The EU-funded WiLiMan-ID project is excited to announce the launch of a brand-new short film series, The Deadly Five. This series is aimed at raising awareness of five critical animal infectious diseases, classified as high priority.
-
NewsGlobal Virus Network meeting unites Caribbean and Latin America to tackle emerging viral threats
A two-day summit focused on collaborative strategies to bolster viral surveillance, diagnostics, vaccine research, and pandemic preparedness across Latin America and the Caribbean, challenges intensified by climate change and globalization.
-
NewsScientists win award for bringing breakthrough HIV treatment lenacapavir into play
Three people have been awarded the AAAS Mani L. Bhaumik Breakthrough of the Year Award for their work on the first HIV drug to offer long-lasting protection from infection — eliminating the need for people to take a daily pill.
-
NewsResearch collaboration takes ‘one health’ approach to study Chagas disease
Researchers have received more than $4 million from federal and non-governmental organizations to support research on Chagas disease prevalence, diagnostics and treatment to benefit both dogs and humans.
-
NewsDisease experts call for reinstatement of CDC’s Healthcare Infection Control Practices Advisory Committee (HICPAC)
The Society for Healthcare Epidemiology of America has called for the reinstatement of CDC’s Healthcare Infection Control Practices Advisory Committee (HICPAC), warning that decades of progress in preventing healthcare-associated infections are under threat.
-
NewsNew CDC nPEP Guidelines should become ‘part of general medical practice’
Health experts say the updated CDC HIV Non-Occupational Post Exposure Prophylaxis (nPEP) Guidelines should be part of general medical practice, as incorporating them will reduce new HIV infections and improve public health.
-
NewsClinical trial underway for potential Long COVID treatment
A clinical trial is underway to assess the effectiveness and safety of sipavibart, AstraZeneca’s long-acting monoclonal antibody designed to provide protection against Covid-19, as a potential treatment for Long Covid.